Safety of Exercise and High-Dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol
This study has been completed.
Study NCT00531050
Information provided by Novartis
First Received: September 17, 2007
Last Updated: July 15, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
